Navigation Links
IADR and GlaxoSmithKline Consumer Healthcare announce winners of 2009 Innovation in Oral Care Awards
Date:3/17/2009

Alexandria, Va. The International Association for Dental Research (IADR) and GlaxoSmithKline (GSK) Consumer Healthcare today announced the 2009 winners of the annual IADR/GSK Innovation in Oral Care Awards. The three prestigious awards recognize research in innovative oral care technologies that may maintain and improve oral health and the quality of life.

In its sixth year of award support, GSK Consumer Healthcare has contributed nearly $1.4 million. Each of the three 2009 winners will receive a $75,000 unrestricted research grant, which is funded by GSK Consumer Healthcare and administered by IADR. The 2009 winners are:

  • Eric Reynolds, B.Sc., Ph.D., The University of Melbourne School of Dental Science, Australia, for "Development of Oxantel to Prevent Periodontopathogenic Biofilm Formation." Oxantel is already approved for use in humans at relatively high concentrations as a treatment for intestinal parasites. Reynolds and his team have patented its use for the treatment of periodontal diseases. Once the efficacy of Oxantel against periodontopathogenic bacterial biofilms has been demonstrated, it should be possible to develop a professional product that will result in improved oral health for persons with periodontitis.

  • Rena D'Souza, B.D.S., M.S., D.D.S., Ph.D., Baylor College of Dentistry, Texas A&M Health Science Center in Dallas, USA, for "Nanostructured Peptide Hydrogels and Stem Cells for Dentin-Pulp Complex Regeneration." This innovative research will develop and test novel peptide-based hydrogels as scaffolds to promote the differentiation of adult stem cells and the formation of dentin and pulp tissues. This biologically based endodontic therapy offers an important alternative for individuals in a clinical situation with an otherwise poor prognosis.

  • Sandra Bordin, Ph.D., The University of Washington School of Dentistry, Seattle, USA, for "Optical Coherence Tomography for Non-invasive Diagnosis of Periodontal Disorders." This proposal plans to develop miniature, high-resolution Optical Coherence Tomography (OCT) imaging needle devices to explore the validity of this bioengineering technology, which would have a near-term impact on oral health improvement by guiding biopsies and monitoring treatment response in a broad range of oral conditions, thus reducing costs of healthcare. In addition, this technology could stimulate the development/analysis of molecular studies aimed at augmenting the innate capacity of soft connective tissues to heal and regenerate.

This year, the IADR/GSK Innovation in Oral Care Awards received 28 applications from teams of researchers from around the globe. Each application was reviewed by a panel of experts under the chairmanship of Dr. Mariano Sanz, Dean, Universidad Complutense de Madrid (Spain) Dental School.

The awards will be presented during the 87th General Session & Exhibition of the IADR, to be held April 1-4, 2009, in Miami, Florida, USA.

"GSK is honored to partner with IADR to continue to offer the Innovation in Oral Care Awards to such talented investigators," said Dr. Stuart R. Smith, Vice President Global Dental Scientific and Professional Communications for GSK. "These teams have garnered ground-breaking research, and I'm confident that this research will produce innovative technologies that can be used to improve oral care."

"IADR is grateful for the tremendous contributions GSK has made to fund the prestigious Innovation in Oral Care Awards," said IADR President J.M. "Bob" ten Cate. "This awards program has received proposals from many superb investigators, and IADR is very pleased with the high aggregate standard of the applications submitted for improving oral health worldwide."


'/>"/>

Contact: Ingrid Thomas
IThomas@iadr.org
703-299-8084
International & American Association for Dental Research
Source:Eurekalert

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
9. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
10. GlaxoSmithKline Presents Innovative Neuroscience Pipeline
11. GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Louis, Missouri (PRWEB) , ... February 10, 2016 ... ... 2016, in San Diego, will bring together more than 200 of the country’s ... healthcare for the future. , “The true benefit of the Forum is the ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... Armune ... Apifiny® across their network of laboratory service centers across the country. Launched in ... aid clinicians in the detection of prostate cancer. Apifiny order volume exceeded 3,000 tests ...
(Date:2/10/2016)... Burnsville MN (PRWEB) , ... February 10, 2016 ... ... announced that it will attend the Ohio Safety Congress and Expo event March ... held at the Greater Columbus Convention Center. , As the longest running ...
(Date:2/10/2016)... , ... February 10, 2016 ... ... – 1 UNF Drive, Jacksonville, FL 32224, February 26th: Amateur & Professional ... Elite Division - Time: 7:00pm – 10:00pm | Ticket Prices $30, Social ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... Anxiety of ... since the start of Medicare Part D a decade ago, according to The ... from older adults on how they are coping with rapidly rising costs. “The ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... 9, 2016 The leader in accelerated orthodontics, ... is the recipient of the 2015 Townie Choice ... Class II medical device that speeds up orthodontic tooth ... pain often associated with treatment, AcceleDent was selected by ... annual Orthotown survey of the most reliable ...
(Date:2/9/2016)... The life of Dr. Jan Vilcek , celebrated immunologist ...  Twists of fate, combined with sheer grit, brought him from ... communist Czechoslovakia to New York City ... history by playing a key role in the development of ...  Dr. Vilcek brings readers along his improbable journey in his ...
(Date:2/9/2016)... The new report "Global Anti-Bacterial Drugs Market Assessment & Forecast: 2015 ... that the North America continued to lead ... that translated into revenues worth US$ 16,907.3 million. ... Asia-Pacific , Latin America , ... global anti-bacterial market is inclined towards North America ...
Breaking Medicine Technology: